Madrigal Pharmaceuticals Inc. and Roche Sign First Amendment to Agreement - SEC Filing
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 30 2026
0mins
Should l Buy ?
Source: moomoo
First Amendment Agreement: Madrigal Pharmaceuticals has entered into a First Amendment to its agreement, indicating a significant update in their contractual obligations or terms.
SEC Filing: The details of this amendment have been disclosed in a filing with the Securities and Exchange Commission (SEC), which is a standard procedure for public companies to ensure transparency.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
